Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

IMNMIMNM
Showing 8 of 10 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in IMMUNOME INC

Yes. Goldman Sachs holds 1,512,489 shares of IMNM (Immunome), worth $32M, as of its Q2 2026 13F filing. It increased the position by 411,013 shares (+37.3%) from Q1 2026. Goldman Sachs has held IMNM since Q1 2024, across 10 quarterly 13F filings.

Current Value

$32M

Current Shares

1.5M

Total Value Change

+$23.7M

Total Shares Change

+943,981

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.5M
+37.3%
$32M0.0%$21.19
38
2026-Q1
Increased
1.1M
+46.3%
$24.1M0.0%$21.87
39
2025-Q4
Increased
752,725
+260.3%
$16.2M0.0%$21.48
45
2025-Q3
Decreased
208,946
-56.3%
$2.4M0.0%$11.71
0
2025-Q2
Increased
478,618
+147.6%
$4.5M0.0%$9.30
43
2025-Q1
Decreased
193,302
-29.4%
$1.3M0.0%$6.73
0
2024-Q4
Decreased
273,761
-51.9%
$2.9M0.0%$10.62
0
2024-Q3
Increased
568,508
+208.6%
$8.3M0.0%$14.62
44

Other major holders of IMNM: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used